Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease

Helen Heslop; Cliona Rooney; Malcolm Brenner; Robert Krance; George Carrum; Benedikt Gahn; Catherine Bollard; Shakila Khan; Adrian Gee; Uday Popat; Mary Gresik; Donna Przepiorka; Ingrid Kuehnle; Bambi Grilley

doi:10.1089/10430340050057530

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease

Helen Heslop, Cliona Rooney, Malcolm Brenner, Robert Krance, George Carrum, Benedikt Gahn, Catherine Bollard, Shakila Khan, Adrian Gee, Uday Popat, Mary Gresik, Donna Przepiorka, Ingrid Kuehnle, Bambi Grilley

Research output: Contribution to journal › Review article › peer-review

17 Scopus citations

Original language	English (US)
Pages (from-to)	1465-1475
Number of pages	11
Journal	Human Gene Therapy
Volume	11
Issue number	10
DOIs	https://doi.org/10.1089/10430340050057530
State	Published - Jul 1 2000

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Genetics

Access to Document

10.1089/10430340050057530

Cite this

Heslop, H., Rooney, C., Brenner, M., Krance, R., Carrum, G., Gahn, B., Bollard, C., Khan, S., Gee, A., Popat, U., Gresik, M., Przepiorka, D., Kuehnle, I., & Grilley, B. (2000). Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. Human Gene Therapy, 11(10), 1465-1475. https://doi.org/10.1089/10430340050057530

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. / Heslop, Helen; Rooney, Cliona; Brenner, Malcolm et al.
In: Human Gene Therapy, Vol. 11, No. 10, 01.07.2000, p. 1465-1475.

Research output: Contribution to journal › Review article › peer-review

Heslop, H, Rooney, C, Brenner, M, Krance, R, Carrum, G, Gahn, B, Bollard, C, Khan, S, Gee, A, Popat, U, Gresik, M, Przepiorka, D, Kuehnle, I & Grilley, B 2000, 'Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease', Human Gene Therapy, vol. 11, no. 10, pp. 1465-1475. https://doi.org/10.1089/10430340050057530

@article{b050cea262594d0e8d5e7b97f9aeef1c,

title = "Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease",

author = "Helen Heslop and Cliona Rooney and Malcolm Brenner and Robert Krance and George Carrum and Benedikt Gahn and Catherine Bollard and Shakila Khan and Adrian Gee and Uday Popat and Mary Gresik and Donna Przepiorka and Ingrid Kuehnle and Bambi Grilley",

year = "2000",

month = jul,

day = "1",

doi = "10.1089/10430340050057530",

language = "English (US)",

volume = "11",

pages = "1465--1475",

journal = "Human Gene Therapy",

issn = "1043-0342",

publisher = "Mary Ann Liebert Inc.",

number = "10",

}

TY - JOUR

T1 - Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease

AU - Heslop, Helen

AU - Rooney, Cliona

AU - Brenner, Malcolm

AU - Krance, Robert

AU - Carrum, George

AU - Gahn, Benedikt

AU - Bollard, Catherine

AU - Khan, Shakila

AU - Gee, Adrian

AU - Popat, Uday

AU - Gresik, Mary

AU - Przepiorka, Donna

AU - Kuehnle, Ingrid

AU - Grilley, Bambi

PY - 2000/7/1

Y1 - 2000/7/1

UR - http://www.scopus.com/inward/record.url?scp=0034235967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034235967&partnerID=8YFLogxK

U2 - 10.1089/10430340050057530

DO - 10.1089/10430340050057530

M3 - Review article

C2 - 10910143

AN - SCOPUS:0034235967

SN - 1043-0342

VL - 11

SP - 1465

EP - 1475

JO - Human Gene Therapy

JF - Human Gene Therapy

IS - 10

ER -

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this